1
The disease is relaitvely rare; the incidence is roughly 2 people per 100,000 per year. Progressive neuro muscular condition characterized by: Weakness Muscle wasting Fasciculations Increased reflexes What is ALS? Cures Fundraising Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gherig’s Disease, is a neurodegenerative disease that affects nerve cells in the brain and the spinal cord, which eventually leads to respitory failure and death. ALS Affects be- tween 20,000- 30,000 people in the U.S. up to 5,000 new cases of ALS are diag- nosed in the U.S. each year. No known cause Family History of ALS Sprcific genetic defect Chane child will get it 90% 50% 20% 5% Is the average age of patients at diagnosis 55 Life rate after diagnosis 3 to 5 years Ice Bucket Challange ALS is not contagious. ALS has no racial, eth- nic or socioeconomic boundary. As many as 30,000 Americans may have ALS at any given time. Riluzole is the only FDA approved to treat ALS. It typically slows the dis- ease by a few months. Has raised $100 Million and counting since late July 2014 ALS is 20% more common in men than in women ALS

Infographic

Embed Size (px)

DESCRIPTION

infographic on ALS

Citation preview

Page 1: Infographic

The disease is relaitvely rare; the incidence is roughly

2 people per 100,000 per year.

Progressive neuro muscular condition characterized by:

Weakness Muscle wasting Fasciculations Increased reflexes

What is ALS? Cures Fundraising

Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gherig’s Disease, is a neurodegenerative disease that affects nerve cells in the brain and the spinal cord, which eventually leads to respitory failure and death.

ALS Affects be-tween 20,000-30,000 people in the U.S. up to 5,000 new cases of ALS are diag-nosed in the U.S. each year.

No known cause

Family History of ALS

Sprcific genetic defect

Chane child will get it

90%

50%

20%

5%

Is the average age of patients at diagnosis

55 Life rate after diagnosis 3 to 5 years

Ice Bucket Challange

ALS is not contagious.

ALS has no racial, eth-nic or socioeconomic boundary.

As many as 30,000 Americans may have ALS at any given time.

Riluzole is the only FDA approved to treat ALS. It typically slows the dis-ease by a few months.

Has raised

$100 Million and counting since late July 2014

ALS is 20% more common in men than in women

ALS